China Meheco Group Co

China Meheco Group Co Interest Coverage

The Interest Coverage Ratio of China Meheco Group Co (600056.SS) as of Oct 27, 2026 is 5.10. In the previous year, Interest Coverage Ratio was 20.19 — a change of -74.72% (lower).

Interest Coverage

5.10

YoY

-74.72%

Last updated:

Interest Coverage Ratio of China Meheco Group Co is 2024 5.10 . Interest Coverage Ratio of China Meheco Group Co was 2023 20.19 . It decreases by -74.72% lower compared to the previous year.

The China Meheco Group Co Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
17.89 CNY
Jan 1, 2018
4.32 CNY
Jan 1, 2019
11.34 CNY
Jan 1, 2020
10.71 CNY
Jan 1, 2021
9.67 CNY
Jan 1, 2022
12.46 CNY
Jan 1, 2023
20.19 CNY
Jan 1, 2024
5.10 CNY
The China Meheco Group Co Interest Coverage history
YEARInterest CoverageYoY
5.10-74.72%
20.19+62.08%
12.46+28.87%
9.67-9.75%
10.71-5.50%
11.34+162.57%
4.32-75.87%
17.89-84.04%
112.08+390.19%
22.86+152.96%
9.04—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

China Meheco Group Co Stock analysis

What does China Meheco Group Co do? China Meheco Group Co., Ltd. generates revenue through its Industrial Pharmaceutical segment, which manufactures and distributes chemical preparations, chemical bulk drugs, biological products, Chinese patent medicine, and herbal decoction pieces. The Commercial Pharmaceutical segment focuses on wholesale and distribution of pharmaceuticals and medical devices. The Trading segment handles international exporting and medical resourcing introduction. The company serves healthcare providers, hospitals, and pharmacies through its wholesale operations, targeting the pharmaceutical and medical device markets in China and internationally. The Industrial Pharmaceutical segment produces chemical preparations, chemical bulk drugs, biological products, Chinese patent medicine, and herbal decoction pieces for distribution. The Commercial Pharmaceutical segment supplies pharmaceuticals and medical devices to healthcare institutions and retailers. The Trading segment facilitates international exports of pharmaceutical products and introduces medical resources globally, catering to global healthcare markets. China Meheco's revenue streams are derived from the sale of pharmaceutical products across its three segments. The Industrial segment manufactures and sells chemical and traditional Chinese medicine products, while the Commercial segment distributes these products through wholesale channels. The Trading segment earns from exporting pharmaceuticals and managing international medical resource procurement for global clients. China Meheco Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about China Meheco Group Co stock

Interest Coverage Ratio of China Meheco Group Co is 5.10 in 2024.

Interest Coverage Ratio of China Meheco Group Co changed from 20.19 to 5.10, representing a -74.72% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio China Meheco Group Co since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's China Meheco Group Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — China Meheco Group Co

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — China Meheco Group Co